S'abonner

Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function - 04/08/18

Doi : 10.1016/j.jaci.2017.10.004 
Matthew C. Altman, MD a, e, Stephen R. Reeves, MD, PhD c, d, Andrew R. Parker, MD a, Elizabeth Whalen, PhD e, Kira M. Misura, PhD f, Kaitlyn A. Barrow, BA d, Richard G. James, PhD d, Teal S. Hallstrand, MD, MPH b, Steven F. Ziegler, PhD e, Jason S. Debley, MD, MPH c, d,
a Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Wash 
b Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Wash 
c Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Wash 
d Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash 
e Benaroya Research Institute, Seattle, Wash 
f Amgen, Inc, Thousand Oaks, Calif 

Corresponding author: Jason S. Debley, MD, MPH, Center for Immunity and Immunotherapies, Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, WA 98105.Center for Immunity and ImmunotherapiesSeattle Children's Research Institute1900 Ninth AveSeattleWA98105

Abstract

Background

Respiratory viral infection in early childhood, including that from respiratory syncytial virus (RSV), has been previously associated with the development of asthma.

Objective

We aimed to determine whether ex vivo RSV infection of bronchial epithelial cells (BECs) from children with asthma would induce specific gene expression patterns and whether such patterns were associated with lung function among BEC donors.

Methods

Primary BECs from carefully characterized children with asthma (n = 18) and matched healthy children without asthma (n = 8) were differentiated at an air-liquid interface for 21 days. Air-liquid interface cultures were infected with RSV for 96 hours and RNA was subsequently isolated from BECs. In each case, we analyzed gene expression using RNA sequencing and assessed differences between conditions by linear modeling of the data. BEC donors completed spirometry to measure lung function.

Results

RSV infection of BECs from subjects with asthma, compared with uninfected BECs from subjects with asthma, led to a significant increase in expression of 6199 genes. There was significantly greater expression of 195 genes in BECs from children with asthma and airway obstruction (FEV1/forced vital capacity < 0.85 and FEV1 < 100% predicted) than in BECs from children with asthma without obstruction, or in BECs from healthy children. These specific genes were found to be highly enriched for viral response genes induced in parallel with types I and III interferons.

Conclusions

BECs from children with asthma and with obstructive physiology exhibit greater expression of types I and III interferons and interferon-stimulated genes than do cells from children with normal lung function, and expression of interferon-associated genes correlates with the degree of airway obstruction. These findings suggest that an exaggerated interferon response to viral infection by airway epithelial cells may be a mechanism leading to lung function decline in a subset of children with asthma.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma, epithelial cells, sequence analysis, RNA, respiratory syncytial virus, type I interferon

Abbreviations used : BEC, BDR, FDR, GO, HRV, ICS, ISG, LDH, MMP, RIG-I, RSV


Plan


 Supported by grants from the National Institutes of Health (R01HL128361, 1U19AI125378) and Amgen,Inc.
 Disclosure of potential conflict of interest: K. M. Misura is an employee and owns stock in Amgen, Inc. R. G. James received a grant from the National Institutes of Health. S. F. Ziegler received a grant from the National Institutes of Health. J. S. Debley received a grant from the National Institutes of Health and Amgen. The rest of the authors declare that they have no relevant conflicts of interest.


© 2017  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 2

P. 451-459 - août 2018 Retour au numéro
Article précédent Article précédent
  • IL-1/inhibitory ?B kinase ?–induced glycolysis augment epithelial effector function and promote allergic airways disease
  • Xi Qian, Reem Aboushousha, Cheryl van de Wetering, Shi B. Chia, Eyal Amiel, Robert W. Schneider, Jos L.J. van der Velden, Karolyn G. Lahue, Daisy A. Hoagland, Dylan T. Casey, Nirav Daphtary, Jennifer L. Ather, Matthew J. Randall, Minara Aliyeva, Kendall E. Black, David G. Chapman, Lennart K.A. Lundblad, David H. McMillan, Anne E. Dixon, Vikas Anathy, Charles G. Irvin, Matthew E. Poynter, Emiel F.M. Wouters, Pamela M. Vacek, Monique Henket, Florence Schleich, Renaud Louis, Albert van der Vliet, Yvonne M.W. Janssen-Heininger
| Article suivant Article suivant
  • Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps
  • Michael A. Kohanski, Alan D. Workman, Neil N. Patel, Li-Yin Hung, Julie P. Shtraks, Bei Chen, Mariel Blasetti, Laurel Doghramji, David W. Kennedy, Nithin D. Adappa, James N. Palmer, De'Broski R. Herbert, Noam A. Cohen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.